Early Toxicity Testing Market Size- By Technique, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
세계 초기 독성 시험 시장 규모는 2033년까지 7.41%의 CAGR을 기록하며 25억 8,000만 달러 규모로 성장할 것으로 예상됩니다.
신규 화합물의 초기 독성 평가는 의약품 개발 및 기존 분자의 치료 가능성을 높이기 위해 사용됩니다. 전임상 단계에서는 물질의 생물종, 장기, 용량에 따른 부작용을 조사하기 위해 다양한 생물학적 시스템에서 수행됩니다. 동물을 이용한 in vivo, 실험실에서 시험하는 in vitro, 컴퓨터상에서 in silico 등 다양한 방법으로 수행됩니다. 또한 화학제품에 대한 우발적 노출을 조사하는 데도 사용됩니다.
규제 당국은 COVID-19 치료제와 백신의 긴급한 필요성을 인식하고 심사 절차를 가속화하고 규제 유연성을 확대했습니다. 이로 인해 승인 기간이 단축되고 실시간 데이터 공유 및 협력이 더욱 중요해져 초기 독성 시험의 규제 환경이 바뀌었을 수 있습니다. 이 전염병은 학계, 산업계, 정부 간의 협력과 연계를 촉진하여 COVID-19 연구 노력을 강화했습니다.
세계 초기 독성 시험 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규모 추정 및 예측, 각 부문별·지역별·주요 국가별 상세 분석, 경쟁 상황, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 소개
제2장 조사 방법
제3장 주요 요약
제4장 시장 역학
- 촉진요인, 억제요인, 기회, 과제 분석
- COVID-19의 시장에 대한 영향
제5장 시장 변수와 전망
- SWOT 분석
- PESTEL 분석
- Porter's Five Forces 분석
- 히트맵 분석
제6장 경쟁 상황
- 제조 거점 분포·판매 지역·제품 유형
- M&A·제휴·제품 발매·협력
제7장 세계의 초기 독성 시험 시장 : 방법별
- 세계 시장 규모, 점유율, 예측
- In vivo
- In silico
- In vitro
제8장 세계의 초기 독성 시험 시장 : 최종사용자별
- 세계 시장 규모, 점유율, 예측
- 제약
- 화장품
- 화학
- 식품
- 기타
제9장 세계의 초기 독성 시험 시장 예측
제10장 세계의 초기 독성 시험 시장 : 지역별
- 시장 규모 및 시장 점유율 추정과 예측
- 아시아태평양
- 유럽
- 중동 및 아프리카
- 북미
- 라틴아메리카
제11장 기업 개요
- Agilent Technologies
- Accelrys
- BD bioscience
- Bio-rad
- Bioanalytical Systems
- Charles River Laboratories
- Evotec AG
- Enzo Biochem Inc
- Eurofins Scientific
- 기타
제12장 결론
제13장 약어 리스트
제14장 참고 링크
ksm
Early Toxicity Testing Market Introduction and Overview
According to SPER market research, 'Early Toxicity Testing Market Size- By Technique, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033' state that the Global Early Toxicity Testing Market is predicted to reach USD 2.58 billion by 2033 with a CAGR of 7.41%.
Early toxicity assessment of novel compounds is used to develop medications and increase the therapeutic potential of existing molecules. It is carried out in pre-clinical phases on numerous biological systems to explore the species, organs, and dose-specific harmful effects of a substance. It can be carried out in a variety of ways, including in vivo on animals, in vitro in laboratories with tests, and in silico on a computer. It is also used to research accidental exposures to a chemical.
Recognizing the urgent need for COVID-19 therapies and vaccinations, regulatory agencies accelerated review processes and extended regulatory flexibility. This may have altered the regulatory landscape for early toxicity testing, with shorter approval timelines and a stronger emphasis on real-time data sharing and collaboration. The epidemic prompted collaboration and collaborations among academia, industry, and government to boost COVID-19 research efforts.
Scope of the Report:
Report Metric Details
Market size available for years 2020-2033
Base year considered 2023
Forecast period 2024-2033
Segments covered By Technique, By End User.
Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
Companies Covered Agilent Technologies, Accelrys, BD bioscience, Bio-rad, Bioanalytical Systems, Charles River Laboratories, Evotec AG Enzo Biochem Inc, Eurofins Scientific
Global Early Toxicity Testing Market Segmentation:
By Technique: Based on the Technique, Global Early Toxicity Testing Market is segmented as; In vivo, In silico, In vitro.
By End User: Based on the End User, Global Early Toxicity Testing Market is segmented as; Pharmaceuticals industry, Cosmetics industry, Chemicals industry, Food industry, Others.
By Region: This research also includes data for North America, Asia-Pacific, Latin America, Middle East & Africa and Europe.
Table of Contents
1. Introduction
- 1.1. Scope of the report
- 1.2. Market segment analysis
2. Research Methodology
- 2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPER's internal database
- 2.1.4. Premium insight from KOL's
- 2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
- 2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
- 4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges
- 4.2. COVID-19 Impacts of the Global Early Toxicity Testing Market.
5. Market variable and outlook
- 5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
- 5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
- 5.3. PORTER's Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
- 5.4. Heat Map Analysis
6. Competitive Landscape
- 6.1. Global Early Toxicity Testing Market Manufacturing Base Distribution, Sales Area, Product Type
- 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Early Toxicity Testing Market
7. Global Early Toxicity Testing Market, By Technique (USD Million) 2020-2033
7.1. Global Early Toxicity Testing Market Size, Share and Forecast, By Technique, 2020-2026
- 7.2. Global Early Toxicity Testing Market Size, Share and Forecast, By Technique, 2027-2033
- 7.3. In vivo
- 7.4. In silico
- 7.5. In vitro
8. Global Early Toxicity Testing Market, By End User (USD Million) 2020-2033
- 8.1. Global Early Toxicity Testing Market Size, Share and Forecast, By End User, 2020-2026
- 8.2. Global Early Toxicity Testing Market Size,Share and Forecast, By End User, 2027-2033
- 8.3. Pharmaceuticals industry
- 8.4. Cosmetics industry
- 8.5. Chemicals industry
- 8.6. Food industry
- 8.7. Others
9. Global Early Toxicity Testing Market Forecast, 2020-2033 (USD Million)
- 9.1. Global Early Toxicity Testing Market Size and Market Share
10. Global Early Toxicity Testing Market, By Region, 2020-2033 (USD Million)
- 10.1. Global Early Toxicity Testing Market Size and Market Share By Region (2020-2026)
- 10.2. Global Early Toxicity Testing Market Size and Market Share By Region (2027-2033)
- 10.3. Asia-Pacific
- 10.3.1. Australia
- 10.3.2. China
- 10.3.3. India
- 10.3.4. Japan
- 10.3.5. South Korea
- 10.3.6. Rest of Asia-Pacific
- 10.4. Europe
- 10.4.1. France
- 10.4.2. Germany
- 10.4.3. Italy
- 10.4.4. Spain
- 10.4.5. United Kingdom
- 10.4.6. Rest of Europe
- 10.5. Middle East and Africa
- 10.5.1. Kingdom of Saudi Arabia
- 10.5.2. United Arab Emirates
- 10.5.3. Qatar
- 10.5.4. South Africa
- 10.5.5. Egypt
- 10.5.6. Morocco
- 10.5.7. Nigeria
- 10.5.8. Rest of Middle East & Africa
- 10.6. North America
- 10.6.1. Canada
- 10.6.2. Mexico
- 10.6.3. United States
- 10.7. Latin America
- 10.7.1. Argentina
- 10.7.2. Brazil
- 10.7.3. Rest of Latin America
11. Company Profile
- 11.1. Agilent Technologies
- 11.1.1. Company details
- 11.1.2. Financial outlook
- 11.1.3. Product summary
- 11.1.4. Recent developments
- 11.2. Accelrys
- 11.2.1. Company details
- 11.2.2. Financial outlook
- 11.2.3. Product summary
- 11.2.4. Recent developments
- 11.3. BD bioscience
- 11.3.1. Company details
- 11.3.2. Financial outlook
- 11.3.3. Product summary
- 11.3.4. Recent developments
- 11.4. Bio-rad
- 11.4.1. Company details
- 11.4.2. Financial outlook
- 11.4.3. Product summary
- 11.4.4. Recent developments
- 11.5. Bioanalytical Systems
- 11.5.1. Company details
- 11.5.2. Financial outlook
- 11.5.3. Product summary
- 11.5.4. Recent developments
- 11.6. Charles River Laboratories
- 11.6.1. Company details
- 11.6.2. Financial outlook
- 11.6.3. Product summary
- 11.6.4. Recent developments
- 11.7. Evotec AG
- 11.7.1. Company details
- 11.7.2. Financial outlook
- 11.7.3. Product summary
- 11.7.4. Recent developments
- 11.8. Enzo Biochem Inc
- 11.8.1. Company details
- 11.8.2. Financial outlook
- 11.8.3. Product summary
- 11.8.4. Recent developments
- 11.9. Eurofins Scientific
- 11.9.1. Company details
- 11.9.2. Financial outlook
- 11.9.3. Product summary
- 11.9.4. Recent developments
- 11.10. Others
12. Conclusion
13. List of Abbreviations
14. Reference Links
